Welcome to our dedicated page for Archer Daniels Midland news (Ticker: ADM), a resource for investors and traders seeking the latest updates and insights on Archer Daniels Midland stock.
Archer Daniels Midland Company reports developments tied to its role as a global agricultural supply chain manager, commodity processor, grain merchandiser, and provider of human and animal nutrition ingredients. Recurring updates cover quarterly and annual results, segment performance in Nutrition and agricultural processing activities, guidance, bio-based solutions, and market conditions affecting crops, oilseeds, corn, wheat, sweeteners, starches, ethanol, and biofuels.
ADM news also includes cash dividend declarations on its common stock, board and governance changes, sustainability and ethics recognition, farmer-resilience partnerships, and investor conference appearances. Company announcements often connect its processing and logistics network with food security, nutrition, agricultural markets, and the bioeconomy.
ADM announces a significant equity investment in Acies Bio, a Slovenia-based biotechnology firm, to enhance its capabilities in precision microbial fermentation. This partnership aims to advance innovative, sustainable solutions in agriculture and food production. ADM's investment, through its corporate venture arm, ADM Ventures, will help accelerate Acies Bio’s platform technologies, improving their infrastructure and high-throughput capabilities. This collaboration opens new growth opportunities in the microbial technology sector, aligning with ADM's commitment to sustainability.
ADM (NYSE: ADM) has agreed to sell its ethanol production complex in Peoria, Illinois, to BioUrja Group. This divestiture will reduce ADM's ethanol capacity by 135 million gallons, allowing the company to redeploy capital into strategic growth investments. CEO Juan Luciano emphasized that this sale aligns with ADM's ongoing transformation and sustainable growth strategy. The transition will be smooth for the approximately 150 employees at the Peoria facility. BioUrja Group looks forward to enhancing its bio-ethanol production capabilities and contributing to the global energy transition.
On October 19, 2021, Solarea Bio, a biotech firm from Cambridge, MA, announced a technology licensing agreement with ADM (NYSE: ADM). This partnership aims to harness microbial technologies developed by Solarea to address inflammatory conditions like osteoporosis. ADM will explore using these microbes in innovative food and beverage solutions targeting health and wellness. Both companies expressed enthusiasm about the collaboration and its potential to create impactful health solutions. This agreement underscores ADM's commitment to expanding its microbiome strategic platform for growth.
ADM, a leader in nutrition, has released its second annual list of global consumer trends based on insights from its Outside Voice platform. Key trends include a focus on holistic nourishment, plant-based diets, gut health awareness, clean sourcing demands, and the humanization of pets. The report highlights consumers' desires for transparency, sustainability, and responsible animal feeding. These insights aim to guide product innovation for brands seeking relevance in an evolving marketplace, reflecting a significant shift in consumer values and behaviors.
ADM (NYSE: ADM) and Qingdao Vland Biotech Group have announced a joint venture aimed at capturing the demand for human probiotics in China. Retail demand for probiotics in China is projected to reach $1 billion in 2022, growing at over 9% annually. The 50-50 joint venture will manufacture and sell human probiotics, leveraging the expertise and capabilities of both companies. Regulatory approval is needed for the venture, which is expected to launch in the first half of 2022. This partnership forms part of ADM's broader strategy to expand its health and wellness portfolio.
ADM Achieves Recognition for Protein Innovation
ADM (NYSE: ADM) has been ranked 27th on Fortune's 2021 Change the World list, recognizing companies with significant social impact. For over 70 years, ADM has led in protein innovation, creating the first plant-based meat alternative and soy-based patty. As a leader in sustainable food sources, ADM is committed to developing nutritious foods for a growing population. They aim to address the need for diverse protein sources, with the goal of producing 60% more food by 2050 to meet global demands.
ADM will release its third quarter 2021 financial results on Tuesday, Oct. 26, 2021, before market opening. A slide presentation will be available for download, and a webcast is scheduled for 8 a.m. Central Time to discuss the results and provide an update on the company. Investors and stakeholders can access the webcast at www.adm.com/webcast. A replay will be available afterwards.
For more information, visit www.adm.com.
ADM (NYSE: ADM) will host a global investor day on Friday, Dec. 10, featuring Chairman and CEO Juan Luciano and CFO Ray Young, who will highlight ADM's strategic achievements and outline the company's growth plan. Further details will be provided in the coming weeks. ADM is a global leader in nutrition, offering innovative solutions for human and animal needs, and emphasizes sustainability in its operations. The investor day aims to share insights on the company's transformation and future direction.
ADM has launched a new automated flavor production facility in Pinghu, Zhejiang Province, China. This 27,000+ square meter facility is designed to be the flavor supply hub for ADM in the Asia-Pacific region, providing geographic advantages and access to top talent.
With advanced technologies and certifications, the facility aims to meet the growing demand for healthy food products. ADM emphasizes its ongoing commitment to growth through strategic acquisitions and technological innovations to support its global nutrition division.
ADM and LG Chem have signed a memorandum of understanding to explore the production of lactic acid in the US, aiming to meet rising demand for plant-based products, including bioplastics.
The joint venture is expected to begin in early 2022, producing high-purity, corn-based lactic acid. The global lactic acid market was valued at USD 2.7 billion in 2020, with an 8% annual growth rate anticipated. Additionally, the companies plan another joint venture to use this lactic acid for producing biodegradable polylactic acid, supporting a projected bioplastics market growth from USD 10.7 billion in 2021 to USD 29.7 billion by 2026.